BNGO
Price:
$0.4433
Market Cap:
$38.12M
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-g...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2018-08-21
Stock Exchange
NASDAQ
Ticker
BNGO
According to Bionano Genomics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.04. This represents a change of -108.57% compared to the average of -0.47 of the last 4 quarters.
The mean historical PE Ratio of Bionano Genomics, Inc. over the last ten years is -3.47. The current 0.04 PE Ratio has changed -215.37% with respect to the historical average. Over the past ten years (40 quarters), BNGO's PE Ratio was at its highest in in the September 2023 quarter at -0.24. The PE Ratio was at its lowest in in the March 2021 quarter at -53.60.
Average
-3.47
Median
-1.86
Minimum
-11.43
Maximum
-0.28
Discovering the peaks and valleys of Bionano Genomics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.15%
Maximum Annual PE Ratio = -0.28
Minimum Annual Increase = -91.28%
Minimum Annual PE Ratio = -11.43
Year | PE Ratio | Change |
---|---|---|
2023 | -0.28 | -91.28% |
2022 | -3.18 | -72.13% |
2021 | -11.43 | 46.37% |
2020 | -7.81 | 1.15% |
2019 | -0.62 | -68.95% |
2018 | -2.00 | 182.01% |
2017 | -0.71 | -58.32% |
The current PE Ratio of Bionano Genomics, Inc. (BNGO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.96
5-year avg
-4.66
10-year avg
-3.47
Bionano Genomics, Inc.’s PE Ratio is less than Intuitive Surgical, Inc. (80.00), greater than Innovative Eyewear, Inc. (-0.60), greater than Stereotaxis, Inc. (-8.46), greater than NEXGEL, Inc. (-4.95), greater than Microbot Medical Inc. (-1.25), less than STAAR Surgical Company (92.03), greater than Envista Holdings Corporation (-2.27), greater than G Medical Innovations Holdings Ltd (0), less than Becton, Dickinson and Company (47.68), less than West Pharmaceutical Services, Inc. (41.34), less than ResMed Inc. (35.24), greater than Wearable Health Solutions, Inc. (-0.18), greater than BioLife Sciences Inc. (0), greater than Psykey, Inc. (-7.55), greater than Predictive Oncology Inc. (-0.30), greater than Sharps Technology, Inc. (-0.72), greater than GlucoTrack, Inc. (-1.91), less than Meihua International Medical Technologies Co., Ltd. (1.39),
Company | PE Ratio | Market cap |
---|---|---|
80.00 | $167.66B | |
-0.60 | $7.07M | |
-8.46 | $178.62M | |
-4.95 | $25.07M | |
-1.25 | $14.46M | |
92.03 | $1.53B | |
-2.27 | $3.00B | |
0 | $1.80M | |
47.68 | $67.25B | |
41.34 | $21.56B | |
35.24 | $35.98B | |
-0.18 | $182.67K | |
0 | $318.35K | |
-7.55 | $387.33K | |
-0.30 | $6.10M | |
-0.72 | $7.85M | |
-1.91 | $14.51M | |
1.39 | $25.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionano Genomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionano Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bionano Genomics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Bionano Genomics, Inc. (BNGO)?
What is the highest PE Ratio for Bionano Genomics, Inc. (BNGO)?
What is the 3-year average PE Ratio for Bionano Genomics, Inc. (BNGO)?
What is the 5-year average PE Ratio for Bionano Genomics, Inc. (BNGO)?
How does the current PE Ratio for Bionano Genomics, Inc. (BNGO) compare to its historical average?